Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Avidity Biosciences Inc

Avidity Biosciences Inc (RNAM) Stock Overview

Explore Avidity Biosciences Inc’s financial performance, market position, analyst ratings, and future outlook.

RNAM●NASDAQ
HealthcareBiotechnology
$72.86
$0.04(0.05%)
U.S. Market opens in 14h 45m

Avidity Biosciences Inc (RNAM)

Meyka AI Score

Z

Key Financials

Market Cap11.3B
P/E Ratio-14.69
EPS (TTM)$-4.19
ROE-0.45%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

RNAM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Avidity Biosciences Inc (NASDAQ: RNAM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Avidity Biosciences Inc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RNAM on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind Avidity Biosciences Inc's NASDAQ-traded stock include a P/E ratio of -14.69 and a market capitalization of 11.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of RNAM on the NASDAQ.

Price Performance (NASDAQ: RNAM)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
2.13%
3-Month Change
0.30%
6-Month Change
0.30%
Year-to-Date (YTD) Change
0.30%
1-Year Change
0.30%
3-Year Change
0.30%
5-Year Change
0.30%
All-Time (Max) Change
0.30%

Contact Information

http://www.aviditybiosciences.com
1 858 401 7900
3020 Callan Road, San Diego, CA, 92121

Company Facts

5,110 Employees
IPO DateJun 12, 2020
CountryUS

Frequently Asked Questions